Published in Gastroenterology on February 01, 2010
High-dose ursodeoxycholic acid is associated with the development of colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis. Am J Gastroenterol (2011) 2.38
Chromoendoscopy for Surveillance in Inflammatory Bowel Disease Does Not Increase Neoplasia Detection Compared With Conventional Colonoscopy With Random Biopsies: Results From a Large Retrospective Study. Am J Gastroenterol (2015) 2.35
Colonoscopy is associated with a reduced risk for colon cancer and mortality in patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol (2014) 2.27
Association between serrated epithelial changes and colorectal dysplasia in inflammatory bowel disease. Gastrointest Endosc (2015) 1.40
Defining quality indicators for best-practice management of inflammatory bowel disease in Canada. Can J Gastroenterol Hepatol (2014) 1.19
MicroRNA214 Is Associated With Progression of Ulcerative Colitis, and Inhibition Reduces Development of Colitis and Colitis-Associated Cancer in Mice. Gastroenterology (2015) 1.01
Primary sclerosing cholangitis: diagnosis, prognosis, and management. Clin Gastroenterol Hepatol (2013) 0.98
Serum inflammatory markers and risk of colorectal cancer in patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol (2014) 0.96
Colon cancer screening and surveillance in inflammatory bowel disease. Clin Endosc (2014) 0.95
Cost-effectiveness analysis of chromoendoscopy for colorectal cancer surveillance in patients with ulcerative colitis. Gastrointest Endosc (2013) 0.94
Surveillance of IBD Using High Definition Colonoscopes Does Not Miss Adenocarcinoma in Patients with Low-grade Dysplasia. Inflamm Bowel Dis (2016) 0.93
Novel diagnostic and therapeutic techniques for surveillance of dysplasia in patients with inflammatory bowel disease. Can J Gastroenterol Hepatol (2014) 0.92
Intestinal cancer in inflammatory bowel disease: natural history and surveillance guidelines. Ann Gastroenterol (2012) 0.90
Field cancerization in the intestinal epithelium of patients with Crohn's ileocolitis. Gastroenterology (2011) 0.89
The valuable role of endoscopy in inflammatory bowel disease. Diagn Ther Endosc (2012) 0.89
Truncated neurokinin-1 receptor is increased in colonic epithelial cells from patients with colitis-associated cancer. Proc Natl Acad Sci U S A (2011) 0.89
Has the risk of colorectal cancer in inflammatory bowel disease decreased? World J Gastroenterol (2013) 0.88
The risk of colorectal cancer in patients with ulcerative colitis. Dig Dis Sci (2014) 0.88
Update on inflammatory bowel disease in patients with primary sclerosing cholangitis. World J Hepatol (2014) 0.88
The histopathological approach to inflammatory bowel disease: a practice guide. Virchows Arch (2014) 0.86
Molecular Alterations of Colorectal Cancer with Inflammatory Bowel Disease. Dig Dis Sci (2015) 0.85
Unique patterns of CpG island methylation in inflammatory bowel disease-associated colorectal cancers. Inflamm Bowel Dis (2011) 0.85
Indications, stains and techniques in chromoendoscopy. QJM (2012) 0.82
The potential for medical therapy to reduce the risk of colorectal cancer and optimize surveillance in inflammatory bowel disease. Gastrointest Endosc Clin N Am (2014) 0.82
Colorectal cancers in ulcerative colitis from a low-prevalence area for colon cancer. World J Gastroenterol (2015) 0.82
Serrated adenoma prevalence in inflammatory bowel disease surveillance colonoscopy, and characteristics revealed by chromoendoscopy and virtual chromoendoscopy. Can J Gastroenterol Hepatol (2014) 0.79
Colorectal cancer surveillance in inflammatory bowel disease: A critical analysis. World J Gastrointest Endosc (2014) 0.78
DNA Methylation and Mutation of Small Colonic Neoplasms in Ulcerative Colitis and Crohn's Colitis: Implications for Surveillance. Inflamm Bowel Dis (2016) 0.78
Biomarker-based prediction of inflammatory bowel disease-related colorectal cancer: a case-control study. Cell Oncol (Dordr) (2011) 0.78
Risk of cancer, with special reference to extra-intestinal malignancies, in patients with inflammatory bowel disease. World J Gastroenterol (2013) 0.78
Advanced colorectal adenomas in patients under 45 years of age are mostly sporadic. Dig Dis Sci (2014) 0.78
Colorectal Cancer Screening in Inflammatory Bowel Disease. Dig Dis Sci (2015) 0.78
Primary Sclerosing Cholangitis with Inflammatory Bowel Disease in Korean Children. Pediatr Gastroenterol Hepatol Nutr (2015) 0.77
Surveillance for colitis-associated colon neoplasia. World J Gastroenterol (2010) 0.77
Statin Use Is Associated With Reduced Risk of Colorectal Cancer in Patients With Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol (2016) 0.77
Quality improvement in gastroenterology clinical practice. Clin Gastroenterol Hepatol (2012) 0.77
Comparison of 4-L Polyethylene Glycol and 2-L Polyethylene Glycol Plus Ascorbic Acid in Patients with Inactive Ulcerative Colitis. Dig Dis Sci (2017) 0.76
Colorectal neoplasia in IBD--a single-center analysis of patients undergoing proctocolectomy. Int J Colorectal Dis (2015) 0.76
Endoscopy: Chromoendoscopy in IBD: indispensable in real-life screening. Nat Rev Gastroenterol Hepatol (2016) 0.76
Crohn's disease: the subsequent visit. Gastroenterol Hepatol (N Y) (2013) 0.76
Elderly patients and inflammatory bowel disease. World J Gastrointest Pharmacol Ther (2016) 0.76
Surgical management of ulcerative colitis. Langenbecks Arch Surg (2011) 0.76
Endoscopic evaluation in diagnosis and management of inflammatory bowel disease. World J Gastrointest Endosc (2016) 0.75
From the surface to the single cell: Novel endoscopic approaches in inflammatory bowel disease. World J Gastroenterol (2015) 0.75
Use of biologics and chemotherapy in patients with inflammatory bowel diseases and cancer. Ann Gastroenterol (2016) 0.75
Surveillance of Inflammatory Bowel Disease. Gastroenterol Hepatol (N Y) (2014) 0.75
Advanced gastrointestinal endoscopic imaging for inflammatory bowel diseases. World J Gastroenterol (2016) 0.75
Endoscopic Therapy in Inflammatory Bowel Diseases. Viszeralmedizin (2015) 0.75
Suitability of surveillance colonoscopy for patients with ulcerative colitis to detect colorectal cancer: current guidelines miss some early-stage cases. Nagoya J Med Sci (2015) 0.75
Development of Advanced Imaging Criteria for the Endoscopic Identification of Inflammatory Polyps. Clin Transl Gastroenterol (2015) 0.75
Preventive health measures in inflammatory bowel disease. World J Gastroenterol (2016) 0.75
Inflammatory bowel disease associated neoplasia: A surgeon's perspective. World J Gastroenterol (2016) 0.75
Characterization of TCP-1 probes for molecular imaging of colon cancer. J Control Release (2016) 0.75
IBD: A timely diagnosis of primary sclerosing cholangitis in IBD. Nat Rev Gastroenterol Hepatol (2016) 0.75
Advanced endoscopic imaging for surveillance for dysplasia and colorectal cancer in inflammatory bowel disease: could the pathologist be further helped? Saudi J Gastroenterol (2014) 0.75
Light and sound - emerging imaging techniques for inflammatory bowel disease. World J Gastroenterol (2016) 0.75
Primary linitis plastica of the entire colon in a background of ulcerative colitis: a case report. World J Surg Oncol (2015) 0.75
Plasminogen activator inhibitor-1 is increased in colonic epithelial cells from patients with colitis-associated cancer. J Crohns Colitis (2012) 0.75
Healthcare maintenance in elderly patients with inflammatory bowel disease. Ann Gastroenterol (2017) 0.75
Chromoendoscopy and Dysplasia Surveillance in Inflammatory Bowel Disease: Past, Present, and Future. Gastroenterol Hepatol (N Y) (2015) 0.75
Pseudopolyps in inflammatory bowel diseases: Have we learned enough? World J Gastroenterol (2017) 0.75
Crohn's disease: a clinical update. Therap Adv Gastroenterol (2015) 0.75
Endoscopic recommendations for colorectal cancer screening and surveillance in patients with inflammatory bowel disease: Review of general recommendations. World J Gastrointest Endosc (2017) 0.75
Endoscopic Surveillance in Long-standing Colitis. Curr Treat Options Gastroenterol (2017) 0.75
Advances in the Diagnosis and Management of Colonic Dysplasia in Patients With Inflammatory Bowel Disease. Gastroenterol Hepatol (N Y) (2017) 0.75
Role of new endoscopic techniques in inflammatory bowel disease management: Has the change come? World J Gastroenterol (2017) 0.75
Survival of Colorectal Cancer in Patients With or Without Inflammatory Bowel Disease: A Meta-Analysis. Dig Dis Sci (2015) 0.75
Endoscopic Diagnosis and Treatment of Precancerous Colorectal Lesions in Patients with Inflammatory Bowel Disease: How Does the Latest SCENIC International Consensus Intersect with Our Clinical Practice? J Transl Int Med (2017) 0.75
Perspectives on endoscopic surveillance of dysplasia in inflammatory bowel disease: a survey of academic gastroenterologists. Endosc Int Open (2017) 0.75
Preventative Care in the Patient with Inflammatory Bowel Disease: What Is New? Dig Dis Sci (2016) 0.75
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet (2008) 30.20
A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science (2006) 27.49
Linking long-term dietary patterns with gut microbial enterotypes. Science (2011) 17.30
Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst (2004) 14.97
Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol (2011) 12.48
Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med (2014) 11.07
Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA (2006) 9.53
Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med (2013) 9.44
Accuracy of CT colonography for detection of large adenomas and cancers. N Engl J Med (2008) 9.32
Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med (2004) 6.42
Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors. J Clin Oncol (2002) 5.91
The association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology (2002) 4.98
Sampling and pyrosequencing methods for characterizing bacterial communities in the human gut using 16S sequence tags. BMC Microbiol (2010) 4.97
Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis. Gastroenterology (2003) 4.84
Serrated lesions of the colorectum: review and recommendations from an expert panel. Am J Gastroenterol (2012) 4.22
Intestinal inflammation and cancer. Gastroenterology (2011) 4.13
Pathology of mouse models of intestinal cancer: consensus report and recommendations. Gastroenterology (2003) 4.10
Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors. Gastroenterology (2007) 3.99
Common variants at five new loci associated with early-onset inflammatory bowel disease. Nat Genet (2009) 3.82
High-throughput retroviral tagging to identify components of specific signaling pathways in cancer. Nat Genet (2002) 3.81
Treating Clostridium difficile infection with fecal microbiota transplantation. Clin Gastroenterol Hepatol (2011) 3.81
Initiation of tumor necrosis factor-α antagonists and the risk of hospitalization for infection in patients with autoimmune diseases. JAMA (2011) 3.58
Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients. Gastroenterology (2004) 3.57
Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke. Nat Genet (2012) 3.40
BRAF mutations in colon cancer are not likely attributable to defective DNA mismatch repair. Cancer Res (2003) 3.39
Idiopathic chronic pancreatitis with periductal lymphoplasmacytic infiltration: clinicopathologic features of 35 cases. Am J Surg Pathol (2003) 3.36
The human gut virome: inter-individual variation and dynamic response to diet. Genome Res (2011) 3.32
Transcolonic endoscopic cholecystectomy: a NOTES survival study in a porcine model (with video). Gastrointest Endosc (2006) 3.32
MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2 alpha. Gastroenterology (2008) 3.29
Use of a patient navigator to increase colorectal cancer screening in an urban neighborhood health clinic. J Urban Health (2005) 3.28
MR elastography of the liver: preliminary results. Radiology (2006) 3.20
Metaplastic esophageal columnar epithelium without goblet cells shows DNA content abnormalities similar to goblet cell-containing epithelium. Am J Gastroenterol (2009) 3.18
Efficacy of anti-tumor necrosis factor therapy in patients with ulcerative colitis. Am J Gastroenterol (2002) 3.01
Extent of low-grade dysplasia is a risk factor for the development of esophageal adenocarcinoma in Barrett's esophagus. Am J Gastroenterol (2007) 3.00
Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett's esophagus. Gastroenterology (2002) 2.88
American Gastroenterological Association Medical Position Statement on the management of gastroesophageal reflux disease. Gastroenterology (2008) 2.79
Stool DNA and occult blood testing for screen detection of colorectal neoplasia. Ann Intern Med (2008) 2.74
Mortality associated with medical therapy versus elective colectomy in ulcerative colitis: a cohort study. Ann Intern Med (2014) 2.73
Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. Gastroenterology (2012) 2.68
Rapid evolution of the human gut virome. Proc Natl Acad Sci U S A (2013) 2.53
Association between vaccination for herpes zoster and risk of herpes zoster infection among older patients with selected immune-mediated diseases. JAMA (2012) 2.51
Risk of lymph node metastasis in T1 carcinoma of the colon and rectum. Dis Colon Rectum (2002) 2.45
Non-steroidal anti-inflammatory drugs and risk of neoplastic progression in Barrett's oesophagus: a prospective study. Lancet Oncol (2005) 2.40
Use of abdominopelvic computed tomography in emergency departments and rates of urgent diagnoses in Crohn's disease. Clin Gastroenterol Hepatol (2011) 2.40
Pathology features in Bethesda guidelines predict colorectal cancer microsatellite instability: a population-based study. Gastroenterology (2007) 2.39
Leukocyte telomere length predicts cancer risk in Barrett's esophagus. Cancer Epidemiol Biomarkers Prev (2007) 2.39
MYH mutations in patients with attenuated and classic polyposis and with young-onset colorectal cancer without polyps. Gastroenterology (2004) 2.35
AGA Institute review of endoscopic sedation. Gastroenterology (2007) 2.35
Cancers complicating inflammatory bowel disease. N Engl J Med (2015) 2.33
Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis. Hum Mol Genet (2003) 2.33
Prognostic significance of defective mismatch repair and BRAF V600E in patients with colon cancer. Clin Cancer Res (2008) 2.32
The risk of mortality in patients with psoriasis: results from a population-based study. Arch Dermatol (2007) 2.32
Mice deficient for all PIM kinases display reduced body size and impaired responses to hematopoietic growth factors. Mol Cell Biol (2004) 2.31
AGA technical review on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology (2010) 2.31
Follow-up of patients with curatively resected colorectal cancer: a practice guideline. BMC Cancer (2003) 2.26
Incidence and mortality of colorectal adenocarcinoma in persons with inflammatory bowel disease from 1998 to 2010. Gastroenterology (2012) 2.26
Development of an internet-based cohort of patients with inflammatory bowel diseases (CCFA Partners): methodology and initial results. Inflamm Bowel Dis (2012) 2.23
NSAIDs modulate CDKN2A, TP53, and DNA content risk for progression to esophageal adenocarcinoma. PLoS Med (2007) 2.23
Defining surgical quality in gastric cancer: a RAND/UCLA appropriateness study. J Am Coll Surg (2013) 2.19
Protocol for the examination of specimens from patients with primary carcinomas of the colon and rectum. Arch Pathol Lab Med (2008) 2.18
Chromoendoscopy-targeted biopsies are superior to standard colonoscopic surveillance for detecting dysplasia in inflammatory bowel disease patients: a prospective endoscopic trial. Am J Gastroenterol (2008) 2.16
Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas. Oncogene (2002) 2.16
Incidence and risk factors for herpes zoster among patients with inflammatory bowel disease. Clin Gastroenterol Hepatol (2006) 2.16
Increased risk for demyelinating diseases in patients with inflammatory bowel disease. Gastroenterology (2005) 2.15
Rates of malignancy associated with juvenile idiopathic arthritis and its treatment. Arthritis Rheum (2012) 2.15
Association of 6-thioguanine nucleotide levels and inflammatory bowel disease activity: a meta-analysis. Gastroenterology (2006) 2.14
Initiation of anti-TNF therapy and the risk of optic neuritis: from the safety assessment of biologic ThERapy (SABER) Study. Am J Ophthalmol (2012) 2.14
Cancer in inflammatory bowel disease. World J Gastroenterol (2008) 2.12
Tricyclic antidepressants for management of residual symptoms in inflammatory bowel disease. J Clin Gastroenterol (2014) 2.11
A prospective randomized trial comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma. Surgery (2005) 2.10
Medical decision analysis for the management of unifocal, flat, low-grade dysplasia in ulcerative colitis. Gastrointest Endosc (2009) 2.07
An optimized patient-reported ulcerative colitis disease activity measure derived from the Mayo score and the simple clinical colitis activity index. Inflamm Bowel Dis (2014) 2.05
Properties of the neosquamous epithelium after radiofrequency ablation of Barrett's esophagus containing neoplasia. Am J Gastroenterol (2009) 2.05
Antibiotic therapy in inflammatory bowel disease: a systematic review and meta-analysis. Am J Gastroenterol (2011) 2.04
Risks of herpes zoster in patients with rheumatoid arthritis according to biologic disease-modifying therapy. Arthritis Care Res (Hoboken) (2015) 2.03
Diagnostic accuracy of MRI for assessment of T category, lymph node metastases, and circumferential resection margin involvement in patients with rectal cancer: a systematic review and meta-analysis. Ann Surg Oncol (2012) 2.00
Corticosteroids and immunomodulators: postoperative infectious complication risk in inflammatory bowel disease patients. Gastroenterology (2003) 1.94
Genome-wide gene expression differences in Crohn's disease and ulcerative colitis from endoscopic pinch biopsies: insights into distinctive pathogenesis. Inflamm Bowel Dis (2007) 1.94
Definition of Barrett's esophagus: time for a rethink--is intestinal metaplasia dead? Am J Gastroenterol (2009) 1.93
Trends in the use of biologic agents among rheumatoid arthritis patients enrolled in the US medicare program. Arthritis Care Res (Hoboken) (2013) 1.92
Clinicopathologic features and survival in fibrolamellar carcinoma: comparison with conventional hepatocellular carcinoma with and without cirrhosis. Mod Pathol (2005) 1.90
Risk of kidney injury following oral phosphosoda bowel preparations. J Am Soc Nephrol (2007) 1.89
Identification of microRNAs associated with ileal and colonic Crohn's disease. Inflamm Bowel Dis (2010) 1.89
Female infertility after ileal pouch-anal anastomosis for ulcerative colitis. Dis Colon Rectum (2004) 1.87
Renal function after orthotopic liver transplantation is predicted by duration of pretransplantation creatinine elevation. Liver Transpl (2005) 1.87
Cohort study of pioglitazone and cancer incidence in patients with diabetes. Diabetes Care (2011) 1.83
Epstein-Barr virus-positive lymphoma in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine. Gastroenterology (2002) 1.80
Morphology of the cardia and significance of carditis in pediatric patients. Am J Surg Pathol (2002) 1.79
Inflammatory bowel disease characteristics among African Americans, Hispanics, and non-Hispanic Whites: characterization of a large North American cohort. Am J Gastroenterol (2006) 1.79
Etiology of nonresponsive celiac disease: results of a systematic approach. Am J Gastroenterol (2002) 1.79
Aberrant methylation of secreted frizzled-related protein genes in esophageal adenocarcinoma and Barrett's esophagus. Int J Cancer (2005) 1.75
Time trends in therapies and outcomes for adult inflammatory bowel disease, Northern California, 1998-2005. Gastroenterology (2009) 1.74
Incidence and prevalence of inflammatory bowel disease in a Northern California managed care organization, 1996-2002. Am J Gastroenterol (2008) 1.72
Primary hepatic angiosarcoma: findings at CT and MR imaging. Radiology (2002) 1.72
Thromboembolic risk among Danish children and adults with inflammatory bowel diseases: a population-based nationwide study. Gut (2011) 1.70
EMR for Barrett's esophagus-related superficial neoplasms offers better diagnostic reproducibility than mucosal biopsy. Gastrointest Endosc (2007) 1.70